Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration

被引:21
作者
Lajtha, A
Sershen, H
Cooper, T
Hashim, A
Gaal, J
机构
[1] NATHAN S KLINE INST PSYCHIAT RES, CTR NEUROCHEM, ORANGEBURG, NY 10962 USA
[2] CHINOIN CHEM & PHARMACEUT WORKS LTD, H-1045 BUDAPEST 4, HUNGARY
关键词
deprenyl metabolism; fluorodeprenyl metabolism; microdialysis of deprenyl metabolites; intracerebral deprenyl administration; METHAMPHETAMINE; DEPRENYL; AMPHETAMINE; MOTONEURONS; AXOTOMY;
D O I
10.1007/BF02532389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the cerebral metabolism of L-deprenyl and its fluoro-derivative pF-deprenyl, assaying the parent compounds, their metabolites desmethyl deprenyl, L-amphetamine, and L-methamphetamine, and the fluoro analogs of these metabolites. We compared the levels of the metabolites after subcutaneous injection with those after intracerebral administration (via microdialysis) of the parent compounds. The assay of the parent compounds and their metabolites was by GC-MS measurement of the components of brain microdialysate samples. After their subcutaneous administration, deprenyl, and F-deprenyl rapidly entered the brain and then their concentration decreased, with an approximate half-life of 4.5 h. After the intracerebral administration the diffusion from the site of administration was minor. A small fraction (a few percent) of the intracerebrally administered deprenyl was metabolized in situ in the brain possibly by a nonenzymatic process. Metabolism of pF-deprenyl was somewhat more rapid. The higher cerebral levels of metabolites after the subcutaneous administration indicate their exogenous origin-metabolism of parent compounds in the periphery and penetration of the brain by the metabolites.
引用
收藏
页码:1155 / 1160
页数:6
相关论文
共 15 条
[1]   POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH ;
LINAUER, W .
JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326
[2]   PHARMACOKINETIC ASPECTS OF L-DEPRENYL (SELEGILINE) AND ITS METABOLITES [J].
HEINONEN, EH ;
ANTTILA, MI ;
LAMMINTAUSTA, RAS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (06) :742-749
[3]  
LEWITT PA, 1993, NEUROLOGY, V43, P31
[4]  
MAGYAR K, 1994, J NEURAL TRANSM-SUPP, P167
[5]  
MAGYAR K, 1993, INHIBITORS MONOAMINE
[6]   (-)-DEPRENYL ALTERS THE SURVIVAL OF ADULT MURINE FACIAL MOTONEURONS AFTER AXOTOMY - INCREASES IN VULNERABLE C57BL STRAIN BUT DECREASES IN MOTOR-NEURON DEGENERATION MUTANTS [J].
OH, C ;
MURRAY, B ;
BHATTACHARYA, N ;
HOLLAND, D ;
TATTON, WG .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 38 (01) :64-74
[7]   DETERMINATION OF AMPHETAMINE, METHAMPHETAMINE AND DESMETHYLDEPRENYL IN HUMAN PLASMA BY GAS-CHROMATOGRAPHY NEGATIVE-ION CHEMICAL IONIZATION MASS-SPECTROMETRY [J].
REIMER, MLJ ;
MAMER, OA ;
ZAVITSANOS, AP ;
SIDDIQUI, AW ;
DADGAR, D .
BIOLOGICAL MASS SPECTROMETRY, 1993, 22 (04) :235-242
[8]   DEPRENYL IS METABOLIZED TO METHAMPHETAMINE AND AMPHETAMINE IN MAN [J].
REYNOLDS, GP ;
ELSWORTH, JD ;
BLAU, K ;
SANDLER, M ;
LEES, AJ ;
STERN, GM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) :542-544
[9]   DEPRENYL REDUCES THE DEATH OF MOTONEURONS CAUSED BY AXOTOMY [J].
SALO, PT ;
TATTON, WG .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 31 (02) :394-400
[10]   PARAVENTRICULAR NUCLEUS - A SITE FOR THE INTEGRATION OF NEUROENDOCRINE AND AUTONOMIC MECHANISMS [J].
SWANSON, LW ;
SAWCHENKO, PE .
NEUROENDOCRINOLOGY, 1980, 31 (06) :410-417